Global Market Study on Polycystic Ovary Syndrome (PCOS) Treatment

Sep 2016| PMR031A| Persistence Market Research

Report Highlights

In a newly published report on Polycystic Ovary Syndrome (PCOS) Drugs, Persistence Market Research analyzes the PCOS drugs market over an eight-year period from 2016 to 2024 and studies the key drivers and trends impacting the market. The primary objective of the report is to provide updates and information related to market opportunities and useful insights into factors that are significantly transforming businesses and enterprises in the global PCOS market.

Polycystic ovary syndrome (PCOS) – also known as Stein-Leventhal Syndrome – is a common hormonal endocrine disorder that affects women of child bearing age i.e. 15 to 49 years. This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body. PCOS mainly occurs due to a combination of environmental and genetic factors, which cause an abnormal function of the hormones present in the pituitary gland that regulate ovulation. Few of the symptoms of PCOS include irregular menstruation, excess facial and body hair, infertility, and acne and other skin problems. PCOS is also associated with diseases such as type 2 diabetes, obesity, heart diseases, acute depression, and obstructive sleep apnea.

Currently, there are no specific diagnostic tests available for the detection of PCOS; however, blood tests, physical examination, vaginal ultrasound, and medical history analysis are widely recommended by general physicians and gynecologists. While there is no cure for PCOS, its symptoms and associated conditions can be managed with the help of lifestyle modification activities, weight loss management, and medications. Currently, no drugs are approved by the FDA and EMA for PCOS. However, oral contraceptives, insulin sensitizing agents, and aromatase inhibitors are used as first line agents for the treatment of irregular menstruation, diabetes, and facial hair growth respectively.   

This report covers the global PCOS drugs market performance in terms of revenue contribution from various segments. Included in the report is a detailed impact analysis of key trends, drivers, restraints, and opportunities influencing the growth of the global polycystic ovary syndrome drugs market. The report begins with an overview of the polycystic ovary syndrome drugs process and the main reasons why patients worldwide are adopting this process. This section also underlines factors influencing the growth of the global polycystic ovary syndrome drugs market along with detailing of the key trends, drivers, restraints, opportunities, and regulations. The report also provides strategic recommendations for key players in the market to strengthen their footprint and ensure their business stays sustainably profitable.

The next few sections provide a detailed analysis for every segment and sub-segment of the global PCOS drugs market in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market Attractiveness Index, and BPS analysis. The report further highlights the growth trends of the polycystic ovary syndrome drugs market by region and presents a market outlook for 2016–2024 – showcasing key regional trends contributing to the growth of the polycystic ovary syndrome drugs market worldwide, as well as an analysis into the extent to which drivers are influencing this market in each region.

The final section of the report includes detailed company profiles with company-specific long-term and short-term strategies, key offerings, and recent developments in the polycystic ovary syndrome drugs market. Some of the leading companies profiled in the report are Sanofi, Novartis, Teva Pharmaceutical Industries Limited, Addex Therapeutics Ltd., BIOCAD, Merck KGaA, and AstraZeneca Plc.

Research Methodology

The report considers 2015 as the base year and provides data for the forecast period 2016–2024. To deduce market size, the report considers various viewpoints based on extensive primary and secondary research. The report begins by sizing the current market – a key indicator of how the market is likely to grow during the forecast period. Given the characteristics of the market, the report presents triangulated data on the basis of supply side and demand side analysis and other dynamics of the global polycystic ovary syndrome market. Key indicators such as number of PCOS patients in each year, adoption of treatment, diagnosis rate, etc., have been considered to arrive at the indicated market numbers.

  • Table 1 : Global Polycystic Ovary Syndrome Drugs Market Value Analysis, by Drug Class, 2015�2024 (US$ Mn)
  • Table 2 : Global Polycystic Ovary Syndrome Drugs Value Analysis, by Distribution Channel, 2015�2024 (US$ Mn)
  • Table 3 : Global Polycystic Ovary Syndrome Drugs Market Value Analysis, by Region, 2015�2024 (US$ Mn)
  • Table 4 : North America Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 5 : North America Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 6 : North America Polycystic Ovary Syndrome Drugs Market Value Analysis, by Distribution Channel, 2015�2024 (US$ Mn)
  • Table 7 : Latin America Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 8 : Latin America Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 9 : Latin America Polycystic Ovary Syndrome Drugs Market Value Analysis, by Distribution Channel, 2015�2024 (US$ Mn)
  • Table 10 : Europe Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 11 : Europe Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 12 : Europe Polycystic Ovary Syndrome Drugs Market Value Analysis, by Distribution Channel, 2015�2024 (US$ Mn)
  • Table 13 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 14 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 15 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value Analysis, by Distribution Channel, 2015�2024 (US$ Mn)
  • Table 16 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 17 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Value Analysis, by Country, 2015�2024 (US$ Mn)
  • Table 18 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Value Analysis, by Distribution Channel, 2015�2024 (US$ Mn)
  • Figure 1 : Global Polycystic Ovary Syndrome Drugs Market Value, 2015�2024
  • Figure 2 : Global Polycystic Ovary Syndrome Drugs Market Value Share By, Drug Class, 2015
  • Figure 3 : Global Polycystic Ovary Syndrome Drugs Market Value Share By, End User, 2015
  • Figure 4 : Global Polycystic Ovary Syndrome Drugs Market Value Share By, Region, 2015
  • Figure 5 : Polycystic Ovary Syndrome Drugs Market Share Analysis, by Drug Class Type (%), 2016-2024
  • Figure 6 : Global Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Drug Class, 2016-2024
  • Figure 7 : Global Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Drug Class, 2016-2024
  • Figure 8 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Contraceptives, 2016 � 2024
  • Figure 9 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Contraceptives Segment, 2016 � 2024 (US$ Mn
  • Figure 10 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Insulin Sensitizing Agents, 2016 � 2024
  • Figure 11 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Insulin Sensitizing Agents Segment, 2016 � 2024 (US$ Mn)
  • Figure 12 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Anti-Depressants, 2016 � 2024
  • Figure 13 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Anti-Depressants Segment, 2016 � 2024 (US$ Mn)
  • Figure 14 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ornithine Decarboxylase Inhibitors, 2016 � 2024
  • Figure 15 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Ornithine Decarboxylase Inhibitors Segment, 2016 � 2024 (US$ Mn)
  • Figure 16 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Aromatase Inhibitors, 2016 � 2024
  • Figure 17 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Aromatase Inhibitors Segment, 2016 � 2024 (US$ Mn)
  • Figure 18 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Diuretics, 2016 � 2024
  • Figure 19 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Diuretics Segment, 2016 � 2024 (US$ Mn)
  • Figure 20 : Global Polycystic Ovary Syndrome Treatment Market Share Analysis, by Distribution Channel (%), 2016 & 2024
  • Figure 21 : Global Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Distribution Channel, 2016-2024
  • Figure 22 : Global Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by End User, 2016-2024
  • Figure 23 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2016 � 2024
  • Figure 24 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Hospital Pharmacies, 2016 � 2024 (US$ Mn)
  • Figure 25 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Drug Stores/OTC, 2016 � 2024
  • Figure 26 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Drug Stores/OTC, 2016 � 2024 (US$ Mn)
  • Figure 27 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by E-commerce, 2016 � 2024
  • Figure 28 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by E-commerce, 2016 � 2024 (US$ Mn)
  • Figure 29 : Global Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Fertility Clinics, 2016 � 2024
  • Figure 30 : Global Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, by Fertility Clinics, 2016 � 2024 (US$ Mn)
  • Figure 31 : Global Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Region, 2016 & 2024
  • Figure 32 : Global Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Region, 2016-2024
  • Figure 33 : Global Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Region, 2016-2024
  • Figure 34 : North America Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), 2016 � 2024
  • Figure 35 : North America Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, 2016 � 2024 (US$ Mn)
  • Figure 36 : North America Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Country, 2016 & 2024 (US$ Mn)
  • Figure 37 : North America Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Country, 2016 & 2024
  • Figure 38 : North America Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 39 : North America Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Drug Class, 2016 & 2024
  • Figure 40 : North America Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 41 : North America Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Drug Class, 2016 � 2024
  • Figure 42 : North America Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 43 : North America Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Distribution Channel, 2016 & 2024
  • Figure 44 : North America Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 45 : North America Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Distribution Channel, 2016 � 2024
  • Figure 46 : Latin America Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), 2016 � 2024
  • Figure 47 : Latin America Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, 2016 � 2024 (US$ Mn)
  • Figure 48 : Latin America Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Country, 2016 & 2024 (US$ Mn)
  • Figure 49 : Latin America Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Country, 2016 & 2024
  • Figure 50 : Latin America Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 51 : Latin America Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Drug Class, 2016 & 2024
  • Figure 52 : Latin America Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 53 : Latin America Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Drug Class, 2016 � 2024
  • Figure 54 : Latin America Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 55 : Latin America Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Distribution Channel, 2016 & 2024
  • Figure 56 : Latin America Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 57 : Latin America Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Distribution Channel, 2016 � 2024
  • Figure 58 : Europe Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), 2016 � 2024
  • Figure 59 : Europe Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, 2016 � 2024 (US$ Mn)
  • Figure 60 : Europe Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Country, 2016 & 2024 (US$ Mn)
  • Figure 61 : Europe Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Country, 2016 & 2024
  • Figure 62 : Europe Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 63 : Europe Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Drug Class, 2016 & 2024
  • Figure 64 : Europe Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 65 : Europe Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Drug Class, 2016 � 2024
  • Figure 66 : Europe Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 67 : Europe Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Distribution Channel, 2016 & 2024
  • Figure 68 : Europe Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 69 : Europe Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Distribution Channel, 2016 � 2024
  • Figure 70 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), 2016 � 2024
  • Figure 71 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, 2016 � 2024 (US$ Mn)
  • Figure 72 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Country, 2016 & 2024 (US$ Mn)
  • Figure 73 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Country, 2016 & 2024
  • Figure 74 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 75 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Drug Class, 2016 & 2024
  • Figure 76 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 77 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Drug Class, 2016 � 2024
  • Figure 78 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 79 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Distribution Channel, 2016 & 2024
  • Figure 80 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 81 : Asia-Pacific Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Distribution Channel, 2016 � 2024
  • Figure 82 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), 2016 � 2024
  • Figure 83 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Absolute $ Opportunity, 2016 � 2024 (US$ Mn)
  • Figure 84 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Country, 2016 & 2024 (US$ Mn)
  • Figure 85 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Country, 2016 & 2024
  • Figure 86 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 87 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Drug Class, 2016 & 2024
  • Figure 88 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Drug Class, 2016 & 2024 (US$ Mn)
  • Figure 89 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Drug Class, 2016 � 2024
  • Figure 90 : Middle East & Africac Polycystic Ovary Syndrome Drugs Market Value and Forecast, by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 91 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Share Analysis (%), by Distribution Channel, 2016 & 2024
  • Figure 92 : Middle East & Africa Polycystic Ovary Syndrome Drugs Market Y-o-Y Growth (%), by Distribution Channel, 2016 & 2024 (US$ Mn)
  • Figure 93 : Middle East & Africac Polycystic Ovary Syndrome Drugs Market Attractiveness Index, by Distribution Channel, 2016 � 2024

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report